These final results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two support the thought of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected disorders. “Total, the discovery in https://kemalx924idu1.wikienlightenment.com/user